INIS
women
100%
patients
60%
veins
47%
esophagus
47%
mortality
47%
kidneys
47%
injuries
47%
liver
47%
covid-19
47%
obesity
47%
carcinomas
47%
symptoms
47%
comparative evaluations
41%
menopause
35%
body composition
35%
hospitals
23%
lipids
23%
bone mineral density
23%
quality of life
23%
weight
17%
design
17%
hypertension
13%
length
11%
blood
11%
concentration
11%
blood serum
11%
interventions
11%
interference
11%
hepatomas
6%
lymph nodes
6%
Keyphrases
Rescue Treatment
47%
Obesity
47%
Older Women
47%
Retrospective Cohort Study
47%
Increased Mortality
47%
Non-cirrhotic Liver
47%
Percutaneous Transhepatic
47%
Portal Vein Stenting
47%
Acute Respiratory Distress Syndrome
47%
Acute Kidney Injury
47%
Acute Variceal Bleeding
47%
Carcinoma
47%
Hospitalized COVID-19 Patients
47%
Postmenopausal Symptoms
47%
Portal Venous Pressure
31%
Portal Vein
31%
Variceal Bleeding
31%
Normal Weight
20%
Hepatocellular Carcinoma
15%
Pharmacological Treatment
15%
Recanalization
15%
Stent Placement
15%
Portal Hypertension
15%
Intensive Care Unit
15%
Metastatic Lymph Node
15%
Hemodynamic Shock
15%
Endoscopic Band Ligation
15%
Sengstaken-Blakemore Tube
15%
Last Line
15%
Recurrent Bleeding
15%
Medicine and Dentistry
Hepatic Portal Vein
47%
Carcinoma
47%
Stenting
47%
Bleeding
47%
Portal Hypertension
18%
Portal Venous Pressure
18%
Intensive Care Unit
9%
Recurrent Disease
9%
Stent Placement
9%
Hepatocellular Carcinoma
9%
Recanalization
9%
Ligation
9%
Sengstaken-Blakemore Tube
9%
Drug Therapy
9%
Shock (Circulatory)
9%
Lymph Node Metastasis
9%
Hemodynamic
9%
